drugset / Trial / NCT04576364
12-hour Versus 24-hour Postpartum Magnesium Sulphate for Preeclamptic Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
To compare the use of magnesium sulfate for 12 hours versus 24 hours in postpartum women with pre-eclampsia with severe features , to ensure maximum efficacy of anticonvulsant action that can be achieved with least exposure to Mgso4 side effects.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2022-11-20
- Completion
- 2022-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Magnesium Sulfate | Other / unclassified | — | — |
Indications
No indication recorded.